Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: A pre-post comparative study

[1]  A. Malhotra,et al.  Inpatient outcomes of preterm infants receiving ω-3 enriched lipid emulsion (SMOFlipid): an observational study , 2018, European Journal of Pediatrics.

[2]  A. Berger,et al.  A Mixed Lipid Emulsion for Prevention of Parenteral Nutrition Associated Cholestasis in Extremely Low Birth Weight Infants: A Randomized Clinical Trial , 2017, The Journal of pediatrics.

[3]  P. Singer,et al.  Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group. , 2017, Clinical nutrition.

[4]  P. Davis,et al.  Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants , 2017, The New England journal of medicine.

[5]  A. Lodha,et al.  Parenteral Fish-Oil Lipid Emulsions in the Prevention of Severe Retinopathy of Prematurity: A Systematic Review and Meta-Analysis , 2016, American Journal of Perinatology.

[6]  A. Lapillonne,et al.  Long-Chain Polyunsaturated Fatty Acids and Clinical Outcomes of Preterm Infants , 2016, Annals of Nutrition and Metabolism.

[7]  V. Kapoor,et al.  Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. , 2015, The Cochrane database of systematic reviews.

[8]  L. Pereira-da-Silva,et al.  Bone metabolism in very preterm infants receiving total parenteral nutrition: do intravenous fat emulsions have an impact? , 2015, Nutrition reviews.

[9]  Ji Hee Kim,et al.  Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. , 2015, The Journal of nutrition.

[10]  J. V. van Goudoever,et al.  Intravenous lipids in preterm infants: impact on laboratory and clinical outcomes and long-term consequences. , 2015, World review of nutrition and dietetics.

[11]  Stacy E. Rustico,et al.  Metabolic bone disease of prematurity. , 2014, Journal of clinical & translational endocrinology.

[12]  F. Vaz,et al.  Growth and Fatty Acid Profiles of VLBW Infants Receiving a Multicomponent Lipid Emulsion From Birth , 2014, Journal of pediatric gastroenterology and nutrition.

[13]  Trevor A. Mori,et al.  Fish Oil (SMOFlipid) and Olive Oil Lipid (Clinoleic) in Very Preterm Neonates , 2014, Journal of pediatric gastroenterology and nutrition.

[14]  S. Beken,et al.  The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial. , 2014, Early human development.

[15]  R. Uauy,et al.  Lipid needs of preterm infants: updated recommendations. , 2013, The Journal of pediatrics.

[16]  Amy G Feldman,et al.  Neonatal Cholestasis. , 2013, NeoReviews.

[17]  M. Skouroliakou,et al.  Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[18]  R. Lauterbach,et al.  Fish-Oil Fat Emulsion Supplementation May Reduce the Risk of Severe Retinopathy in VLBW Infants , 2011, Pediatrics.

[19]  E. Tomsits,et al.  Safety and Efficacy of a Lipid Emulsion Containing a Mixture of Soybean Oil, Medium-chain Triglycerides, Olive Oil, and Fish Oil: A Randomised, Double-blind Clinical Trial in Premature Infants Requiring Parenteral Nutrition , 2010, Journal of pediatric gastroenterology and nutrition.

[20]  L. Doyle,et al.  Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. , 2009, JAMA.

[21]  R. Deckelbaum,et al.  Inclusion of 10% fish oil in mixed medium-chain triacylglycerol-long-chain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids. , 2008, The American journal of clinical nutrition.

[22]  B. Koletzko,et al.  Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. , 2008, Clinical nutrition.

[23]  C. Valim,et al.  Safety and Efficacy of a Fish-Oil–Based Fat Emulsion in the Treatment of Parenteral Nutrition–Associated Liver Disease , 2008, Pediatrics.

[24]  B. Sharda.  Free Radicals: Emerging Challenge in Environmental Health Research in Childhood and Neonatal Disorders , 2006, International journal of environmental research and public health.

[25]  K. Mayer,et al.  Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients , 2006, European journal of nutrition.

[26]  P. Haggarty.  Effect of placental function on fatty acid requirements during pregnancy , 2004, European Journal of Clinical Nutrition.

[27]  M. Walsh,et al.  Impact of a Physiologic Definition on Bronchopulmonary Dysplasia Rates , 2004, Pediatrics.

[28]  E. Schlotzer,et al.  Elimination and Tolerance of a New Parenteral Lipid Emulsion (SMOF) – A Double-Blind Cross-Over Study in Healthy Male Volunteers , 2004, Annals of Nutrition and Metabolism.

[29]  E. Birch,et al.  Essential fatty acids in visual and brain development , 2001, Lipids.

[30]  O. Saugstad.  Update on oxygen radical disease in neonatology , 2001, Current opinion in obstetrics & gynecology.

[31]  D. Thibeault.  THE PRECARIOUS ANTIOXIDANT DEFENSES OF THE PRETERM INFANT , 2000, American journal of perinatology.

[32]  K. Iyer,et al.  The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. , 1998, Nutrition.

[33]  R. Kliegman,et al.  Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness , 1987, Current Problems in Pediatrics.